Bupe vaccine 125% and Ropi vaccine in candidates for painless labor. Other complications of spinal and epidural anesthesia during labor and delivery
Conditions
Interventions
Intervention 1: Intervention group: Bupevacain 125% (Varian Farmed_Iran) 4 to 6 milliliters and Dexmedetomidine (Exir_Iran) 5 micrograms. Intervention 2: Intervention group: 16 milligrams of Ropivacai
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: All patients who are candidates for painless labor visiting Sina Rezaei Ashtiani Hospital in Arak All patients who are candidates for painless labor within the age range of 15 to 50 years All patients who are Nulliparous Patients without a history of abortion No sensitivity to Bupivacaine and Ropivacaine Having informed consent for painless labor and participation in the mentioned study
Exclusion criteria
Exclusion criteria: All patients in whom painless labor has failed The occurrence of sensitivity to Bupivacaine and Ropivacaine. The occurrence of seizures during painless labor. The occurrence of total spinal symptoms during painless labor All patients who experience apnea during painless labor and require respiratory support
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain-free labor management. Timepoint: After the completion of the second stage of labor. Method of measurement: Questionnaire and recording of vital signs, Apgar score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Shokrpour
Arak University of Medical Sciences
Outcome results
None listed